openPR Logo
Press release

CINV Existing and Pipeline Drugs Market Outlook 2031 Forecasts Exceeding US$ 3.2 Billion by 2031, with a 5.8% CAGR Growth from 2022

The market for Chemotherapy-Induced Nausea and Vomiting (CINV) existing and pipeline drugs is witnessing steady growth, driven by advancements in pharmaceutical research and the rising prevalence of cancer worldwide. With a market value of US$ 1.9 billion in 2021 and a projected CAGR of 5.8% from 2022 to 2031, the global CINV existing and pipeline drugs market is expected to surpass a value of US$ 3.2 billion by the end of 2031.

Market Overview

Chemotherapy-induced nausea and vomiting (CINV) remains a significant challenge for cancer patients undergoing chemotherapy. Effective management of CINV is crucial for improving patient quality of life and treatment outcomes. The market for CINV drugs encompasses both existing treatments and promising pipeline drugs aimed at addressing this unmet medical need.

Request Sample Copy of Market Research Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=776&utm_source=OpenPR_Sandeep&utm_medium=OpenPR

Market Segmentation

The CINV existing and pipeline drugs market is segmented based on various factors:

Major Drugs: Including Aloxi (Palonosetron), Zofran Generic (Ondansetron), Kytril Generic (Granisetron), Emend (Aprepitant), Akynzeo (Netupitant-Palonosetron), SUSTOL (Extended Release Granisetron Injection), and Rolapitant, among others.
Regions Covered: Encompassing North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa, reflecting the global distribution of cancer patients and pharmaceutical research activities.

Key Developments

Recent developments in the global CINV existing and pipeline drugs market include:

Commercial Vision Unveiling: Tetra Bio-Pharma's strategy to bring innovative therapies to patients suffering from chemotherapy-induced nausea and vomiting.
Clinical Studies Commencement: Nuformix's initiation of clinical studies for NXP001, utilizing cocrystal technology for pharmaceutical development.
Product Launches: Glenmark Pharmaceuticals' introduction of Akynzeo for chemotherapy-induced nausea in India and Nepal, offering a combination of netupitant and palonosetron to address patient needs.

Request TOC of Research Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=776&utm_source=OpenPR_Sandeep&utm_medium=OpenPR

Market Drivers and Challenges

Key drivers propelling the growth of the CINV existing and pipeline drugs market include:

Rising Cancer Incidence: Increasing prevalence of cancer globally, leading to a higher demand for effective CINV management strategies.
Advancements in Drug Development: Technological advancements in pharmaceutical research, including novel drug formulations, targeted therapies, and combination treatments.
Growing Awareness: Rising awareness among healthcare professionals and patients regarding the importance of CINV prevention and management.

However, challenges such as regulatory hurdles, drug development costs, and competition from alternative therapies may hinder market growth.

Market Trends

Emerging trends in the CINV existing and pipeline drugs market include:

Targeted Therapies: Development of targeted therapies and personalized medicine approaches for more effective and tailored CINV management.
Combination Therapies: Exploration of combination therapies and multi-modal approaches to address different aspects of CINV, including acute and delayed phases.

Future Outlook

The future outlook for the CINV existing and pipeline drugs market remains promising, with continued focus on research and development, clinical trials, and regulatory approvals. Market players are expected to invest in innovative drug formulations, patient-centric approaches, and strategic collaborations to address the evolving needs of cancer patients.

Competitive Landscape

Key players in the global CINV existing and pipeline drugs market include pharmaceutical companies such as Glenmark Pharmaceuticals, Tetra Bio-Pharma, Nuformix, and others. These companies are actively engaged in research and development activities, clinical trials, and product launches to expand their market presence and address unmet medical needs in CINV management.

Buy Full Report Here: https://www.transparencymarketresearch.com/checkout.php?rep_id=776<ype=S&utm_source=OpenPR_Sandeep&utm_medium=OpenPR

Top Market Research Reports:

Mice Model Market: https://www.globenewswire.com/en/news-release/2023/05/02/2659182/0/en/Mice-Model-Market-to-Reach-USD-2-3-Bn-Growing-at-a-CAGR-of-6-2-from-2021-to-2028-Global-Analysis-by-Transparency-Market-Research.html

Recycled Aluminum Market: https://www.globenewswire.com/en/news-release/2023/04/29/2657953/0/en/Recycled-Aluminum-Market-to-Grow-at-a-CAGR-of-8-9-during-the-Forecast-Period-2023-2031-TMR-Study.html

State Tower, 90 State Street, Suite 700,
Albany NY - 12207, United States

About Us Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.

Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release CINV Existing and Pipeline Drugs Market Outlook 2031 Forecasts Exceeding US$ 3.2 Billion by 2031, with a 5.8% CAGR Growth from 2022 here

News-ID: 3385043 • Views:

More Releases from Transparency Market Research

Global Solar Powered Agricultural Dryer Market to Exceed USD 2.4 Billion by 2031 - Transparency Market Research
Global Solar Powered Agricultural Dryer Market to Exceed USD 2.4 Billion by 2031 …
The global solar powered agricultural dryer market, valued at US$ 1.6 billion in 2022, is projected to grow at a CAGR of 5.8% from 2023 to 2031, reaching US$ 2.4 billion by the end of 2031. Rising investments in renewable energy, growing awareness of sustainable agricultural practices, and the rapid expansion of the agricultural sector driven by population growth are key factors fueling market growth. Uncover essential discoveries and trends from
Technetium-99m Market Forecast 2034: Rising Demand for Diagnostic Imaging and Radiopharmaceuticals to Propel Market Expansion | Transparency Market Research, Inc
Technetium-99m Market Forecast 2034: Rising Demand for Diagnostic Imaging and Ra …
The global Technetium‐99m Market was valued at US$ 6.0 Billion in 2023 and is projected to grow at a CAGR of 3.3% from 2024 to 2034, surpassing US$ 8.6 Billion by the end of the forecast period. Advancements in nuclear imaging infrastructure, government-backed healthcare initiatives, and an increasing demand for precise diagnostic procedures are fueling this growth. Discover essential conclusions and data from our Report in this sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=77100 Analysts' Viewpoint The Technetium‐99m
Equine Diagnostic Services Market Outlook 2030: From US$ 168 Million in 2019 to US$ 280 Million by 2030, Driven by Rising Equine Diseases and Diagnostic Advancements
Equine Diagnostic Services Market Outlook 2030: From US$ 168 Million in 2019 to …
The global Equine Diagnostic Services Market, valued at approximately US$ 168 million in 2019, is projected to expand at a compound annual growth rate (CAGR) of ~5% from 2020 to 2030, reaching around US$ 280 million by 2030. Equine diagnostic services, encompassing tests like genetic, infectious disease, and imaging diagnostics, are critical for managing horse health in veterinary hospitals, clinics, and mobile settings. The market is driven by increasing equine
Digital Printing Market to Reach USD 54.4 Billion by 2034, Growing at a CAGR of 6.1%
Digital Printing Market to Reach USD 54.4 Billion by 2034, Growing at a CAGR of …
The digital printing market is experiencing strong growth, driven by rapid technological advancements, rising demand for personalized and on-demand printing, and an increasing focus on sustainable solutions. Digital printing allows for the direct transfer of digital files onto a wide range of substrates, offering high-resolution output with greater speed and flexibility. Its adaptability has led to broad adoption across industries such as packaging, textiles, publishing, and advertising-sectors where customization, efficiency,

All 5 Releases


More Releases for CINV

Emerging Trends Influencing The Growth Of The Chemotherapy-Induced Nausea and Vo …
The Chemotherapy-Induced Nausea and Vomiting (CINV) Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. How Big Is the Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size Expected to Be by 2034? There has been a notable growth in the market size of chemotherapy-induced nausea and vomiting (CINV)
Key Influencer in the Chemotherapy-Induced Nausea and Vomiting (CINV) Market 202 …
How Are the key drivers contributing to the expansion of the chemotherapy-induced nausea and vomiting (cinv) market? The escalating cases of cancer are expected to foster the expansion of the market for chemotherapy-induced nausea and vomiting (CINV). This rise is due to the uncontrolled development and spread of cancer cells in the body. As cancer prevalence increases, there's an increased drive to produce highly effective and specific anti-emetic treatments, which would
Advancements and Trends in the Global Chemotherapy-induced Nausea and Vomiting ( …
Introduction: The realm of cancer treatment is a dynamic arena where advancements continuously unfold. Among the multitude of challenges that cancer patients face, chemotherapy-induced nausea and vomiting (CINV) is a formidable adversary. In this article, we delve into the intricate landscape of the CINV market, exploring its evolution, current state, and future prospects. Understanding CINV: CINV, an acronym that echoes the discomfort experienced by countless individuals, stands for chemotherapy-induced nausea and vomiting. This
CINV Existing and Pipeline Drugs Market: Rising Demand for CINV Drugs Owing to I …
CINV drugs are administered to patients suffering from vomiting and nausea that occurs as a side effect of chemotherapy. CINV can hinder the progress of patients undergoing chemotherapy, making it very crucial for oncologists to prescribe the right kind of CINV drugs to alleviate the discomfort. Delayed CINV and acute CINV are the two major subtypes of this condition. While the former occurs up to five days after treatment, the
CINV Existing and Pipeline Drugs Market : Growing number of patients undergoing …
The growth of the global chemotherapy induced nausea and vomiting (CINV) market will be steered by the growing number of patients undergoing chemotherapy and a number of new drugs expected to be approved in the near future, says Transparency Market Research. In its report, titled “CINV Existing and Pipeline Drugs Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 – 2020,” the business intelligence firm says that
Global Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Market Research Re …
This report studies Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering GlaxoSmithKline Plc Helsinn Group Heron Therapeutics Merck & Co Inc Tesaro ... Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of